1 King William Street

London EC4N 7AF


Tel:  0203-858-8185

Fax: 0203-858-8188

  • GBX Events
  • Gbx Events (Summit) You Tube
  • Gbx Events (Summit) Twitter

© 2019 by GBX. Proudly created with GBX Events Ltd.
Company Number: 11782795 - VAT: 317674779 UK

Cell & Gene Therapy Innovation Speaker

Ajan Reginald


Ajan Reginald is a Biotech entrepreneur and the co-founder and Chief Executive of Celixir plc. Celixir plc is a British cellular medicines company with drugs in late-stage clinical trials for heart failure and tendon repair and an extensive in-house product pipeline. The founders Ajan and Professor Sir Martin Evans (2007 Nobel Laureate) invented Celixir's technology platform to discovery novel cellular medicines and discovered the Heartcel and Tendoncel medicines. Celixir is well funded and considering an IPO in 2018. Prior to Celixir, Ajan held positions with Roche as the Global Head of Emerging Technologies and Business Development Director, Roche Pharmaceuticals. And with Boston Consulting Group in Zurich and Chicago.